About Index Trending news
Lists
Pricing
Rgenix

Rgenix

Rgenix

Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world's first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients.

Elsewhere

Alexa global traffic share

15 Jun 2016
$33,000,000
Venture capital (Series B)

Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK

Xconomy
+1